Streptomyces parvulus

Last updated

Streptomyces parvulus
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Streptomycetales
Family: Streptomycetaceae
Genus: Streptomyces
Species:
S. parvulus
Binomial name
Streptomyces parvulus
corrig. Waksman and Gregory 1954 (Approved Lists 1980) [1]
Type strain
AS 4.0611, ATCC 12434, ATCC 19796, BCRC 12046, BootsFD1327, CBS 418.59, CBS 548.68, CCRC 12046, CGMCC 4.0611, CGMCC 4.1094, CUB 510, DSM 40048, ETH 12648, ETH 14318, ETH 31592, G-376, HUT-6081 , ICMP 12845, ICMP 156, IFO 13193, IMET 41380, IMRU 3677, ISP 5048, JCM 4068, JCM 4601, KCC S-0068, KCC S-0601, KCCS-0068, KCCS-0601, Lanoot R-8673, LMG 19312, NBRC 13193, NCIB 11240, NCIMB 11240, NRRL B-1628, NRRL-ISP 5048, PSA 146, R-8673, RIA 1075, RIA 307, RIA 507, UNIQEM 182, VKM Ac-1063, VTT E-991419, Waksman3677, WC 3677 [2]
Synonyms
  • Streptomyces parvullusWaksman and Gregory 1954 (Approved Lists 1980)

Streptomyces parvulus is a bacterium species from the genus of Streptomyces which has been isolated from soil. [1] [3] Streptomyces parvulus produces the peptide antibiotic Actinomycin D and the angiogenesis inhibitor borrelidin and manumycin A, himalomycin A, himalomycin B and kynurenine. [4] [5] [6] [7] [8] [9] [10]

Contents

Further reading

See also

Related Research Articles

<span class="mw-page-title-main">Neomycin</span> Type of antibiotic

Neomycin is an aminoglycoside antibiotic that displays bactericidal activity against gram-negative aerobic bacilli and some anaerobic bacilli where resistance has not yet arisen. It is generally not effective against gram-positive bacilli and anaerobic gram-negative bacilli. Neomycin comes in oral and topical formulations, including creams, ointments, and eyedrops. Neomycin belongs to the aminoglycoside class of antibiotics that contain two or more amino sugars connected by glycosidic bonds.

<span class="mw-page-title-main">Teicoplanin</span> Pharmaceutical drug

Teicoplanin is an semisynthetic glycopeptide antibiotic with a spectrum of activity similar to vancomycin. Its mechanism of action is to inhibit bacterial cell wall peptidoglycan synthesis. It is used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.

<i>Streptomyces</i> Genus of bacteria

Streptomyces is the largest genus of Actinomycetota, and the type genus of the family Streptomycetaceae. Over 700 species of Streptomyces bacteria have been described. As with the other Actinomycetota, streptomycetes are gram-positive, and have very large genomes with high GC content. Found predominantly in soil and decaying vegetation, most streptomycetes produce spores, and are noted for their distinct "earthy" odor that results from production of a volatile metabolite, geosmin. Different strains of the same species may colonize very diverse environments.

In organic chemistry, polyketides are a class of natural products derived from a precursor molecule consisting of a chain of alternating ketone and methylene groups: [−C(=O)−CH2−]n. First studied in the early 20th century, discovery, biosynthesis, and application of polyketides has evolved. It is a large and diverse group of secondary metabolites caused by its complex biosynthesis which resembles that of fatty acid synthesis. Because of this diversity, polyketides can have various medicinal, agricultural, and industrial applications. Many polyketides are medicinal or exhibit acute toxicity. Biotechnology has enabled discovery of more naturally-occurring polyketides and evolution of new polyketides with novel or improved bioactivity.

<span class="mw-page-title-main">Dactinomycin</span> Chemical compound

Dactinomycin, also known as actinomycin D, is a chemotherapy medication used to treat a number of types of cancer. This includes Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, trophoblastic neoplasm, testicular cancer, and certain types of ovarian cancer. It is given by injection into a vein.

<span class="mw-page-title-main">Novobiocin</span> Chemical compound

Novobiocin, also known as albamycin, is an aminocoumarin antibiotic that is produced by the actinomycete Streptomyces niveus, which has recently been identified as a subjective synonym for S. spheroides a member of the class Actinomycetia. Other aminocoumarin antibiotics include clorobiocin and coumermycin A1. Novobiocin was first reported in the mid-1950s.

The aminocyclitols are compounds related to cyclitols. They possess features of relative and absolute configuration that are characteristic of their class and have been extensively studied; but these features are not clearly displayed by general methods of stereochemical nomenclature, so that special methods of specifying their configuration are justified and have long been used. In other than stereochemical respects, their nomenclature should follow the general rules of organic chemistry.

<i>Saccharopolyspora erythraea</i> Species of bacterium

Saccharopolyspora erythraea is a species of actinomycete bacteria within the genus Saccharopolyspora.

L-olivosyl-oleandolide 3-O-methyltransferase is an enzyme with systematic name S-adenosyl-L-methionine:L-olivosyl-oleandolide B 3-O-methyltransferase. This enzyme catalyses the following chemical reaction

Streptomyces isolates have yielded the majority of human, animal, and agricultural antibiotics, as well as a number of fundamental chemotherapy medicines. Streptomyces is the largest antibiotic-producing genus of Actinomycetota, producing chemotherapy, antibacterial, antifungal, antiparasitic drugs, and immunosuppressants. Streptomyces isolates are typically initiated with the aerial hyphal formation from the mycelium.

<i>Streptomyces antibioticus</i> Species of bacterium

Streptomyces antibioticus is a gram-positive bacterium discovered in 1941 by Nobel-prize-winner Selman Waksman and H. Boyd Woodruff. Its name is derived from the Greek "strepto-" meaning "twisted", alluding to this genus' chain-like spore production, and "antibioticus", referring to this species' extensive antibiotic production. Upon its first characterization, it was noted that S. antibioticus produces a distinct soil odor.

Streptomyces capoamus is a bacterium species from the genus of Streptomyces which has been isolated from soil from Iceland. Streptomyces capoamus produces capomycin, ciclamycin O, ciclamycin 4, anthracycline, ciclacidin A, ciclacidin B and ciclamicin.

Streptomyces cyaneofuscatus is a bacterium species from the genus of Streptomyces which has been isolated from soil in Daghestan in Russia. Streptomyces cyaneofuscatus can be used for valinomycin biosynthesis.

Streptomyces diastatochromogenes is a bacterium species from the genus of Streptomyces. Streptomyces diastatochromogenes produces polyketomycin, concanamycin A, concanamycin B, concanamycin C, momofulvenone A, azdimycin, toyocamycin and oligomycins.

Streptomyces griseoflavus is a bacterium species from the genus of Streptomyces which has been isolated from garden soil. Streptomyces griseoflavus produces bicozamycin, colabomycins A, colabomycins C, germacradienol and hormaomycin.

Streptomyces longisporoflavus is a bacterium species from the genus of Streptomyces which has been isolated from soil. Streptomyces longisporoflavus produces tetronasin and staurosporine.

Streptomyces lydicus is a bacterium species from the genus of Streptomyces which has been isolated from soil in the United States. Streptomyces lydicus produces actithiazic acid, natamycin, lydimycin, streptolydigin, and 1-deoxygalactonojirimycin. Streptomyces lydicus can be used as an agent against fungal plant pathogens like Fusarium, Pythium, Phytophthora, Rhizoctonia and Verticillum.

<i>Streptomyces olivaceus</i> Species of bacterium

Streptomyces olivaceus is a bacterium species from the genus of Streptomyces which has been isolated from soil. Streptomyces olivaceus produces granaticin, elloramycin, tetroazolemycin A and tetroazolemycin B. Streptomyces olivaceus can be used to produce vitamin B12.

<span class="mw-page-title-main">Borrelidin</span> Chemical compound

Borrelidin is an 18-membered polyketide macrolide derived from several Streptomyces species. First discovered in 1949 from Streptomyces rochei, Borrelidin shows antibacterial activity by acting as an inhibitor of threonyl-tRNA synthetase and features a nitrile moiety, a unique functionality in natural products., Borrelidin also exhibits potent angiogenesis inhibition, which was shown in a rat aorta matrix model. Other studies have been performed to show that low concentrations of borrelidin can suppress growth and induce apoptosis in malignant acute lymphoblastic leukemia cells. Borredlidin's antimalarial activity has also been shown in vitro and in vivo.

Tylactone synthase or TYLS is a Type 1 polyketide synthase. TYLS is found in strains of Streptomyces fradiae and responsible for the synthesis of the macrolide ring, tylactone, the precursor of an antibiotic, tylosin. TYLS is composed of five large multi-functional proteins, TylGI-V. Each protein contains either one or two modules. Each module consists of a minimum of a Ketosynthase (KS), an Acyltransferase (AT), and an Acyl carrier protein (ACP) but may also contain a Ketoreductase (KR), Dehydrotase (DH), and Enoyl Reductase (ER) for additional reduction reactions. The domains of TYLS have similar activity domains to those found in other Type I polyketide synthase such as 6-Deoxyerythronolide B synthase (DEBS). The TYLS system also contains a loading module consisting of a ketosynthase‐like decarboxylase domain, an acyltransferase, and acyl carrier protein. The terminal Thioesterase terminates tylactone synthesis by cyclizing the macrolide ring. After the TYLS completes tylactone synthesis, the tylactone molecule is modified by oxidation at C-20 and C-23 and glycosylation of mycaminose, mycinose, and mycarose to produce tylosin.

References

  1. 1 2 LPSN bacterio.net
  2. Straininfo of Streptomyces parvulus
  3. Deutsche Sammlung von Mikroorganismen und Zellkulturen
  4. Queiroz Sousa, Maria de Fátima Vieira de; Lopes, Carlos Edison; Pereira Júnior, Nei (September 2001). "A chemically defined medium for production of actinomycin D by Streptomyces parvulus". Brazilian Archives of Biology and Technology. 44 (3): 227–231. doi: 10.1590/S1516-89132001000300002 .
  5. Inbar, L; Lapidot, A (September 1988). "Metabolic regulation in Streptomyces parvulus during actinomycin D synthesis, studied with 13C- and 15N-labeled precursors by 13C and 15N nuclear magnetic resonance spectroscopy and by gas chromatography-mass spectrometry". Journal of Bacteriology. 170 (9): 4055–64. doi:10.1128/jb.170.9.4055-4064.1988. PMC   211409 . PMID   3410824.
  6. Olano, C; Wilkinson, B; Sánchez, C; Moss, SJ; Sheridan, R; Math, V; Weston, AJ; Braña, AF; Martin, CJ; Oliynyk, M; Méndez, C; Leadlay, PF; Salas, JA (January 2004). "Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tü4055: cluster analysis and assignment of functions". Chemistry & Biology. 11 (1): 87–97. doi: 10.1016/j.chembiol.2003.12.018 . PMID   15112998.
  7. Brown, Dale; Hitchcock, Michael J. M.; Katz, Edward (June 1986). "Purification and characterization of kynurenine formamidase activities from". Canadian Journal of Microbiology. 32 (6): 465–472. doi:10.1139/m86-086. PMID   2425918.
  8. Diana, Patrizia; Girolamo, Cirrincione (2015). Biosynthesis of Heterocycles: From Isolation to Gene Cluste. John Wiley & Sons. ISBN   978-1-118-96042-4.
  9. Blunt, John; Munro, Murray H.G., eds. (2008). Dictionary of marine natural products with CD-ROM. Boca Raton: Taylor & Francis. ISBN   978-0-8493-8217-8.
  10. UniProt